Amphetamine-induced toxicity in dopamine terminals in CD-1 and C57BL/6J mice: Complex roles for oxygen-based species and temperature regulation

I. N. Krasnova, B. Ladenheim, S. Jayanthi, J. Oyler, Timothy H Moran, M. A. Huestis, J. L. Cadet

Research output: Contribution to journalArticle

Abstract

In order to examine differential strain susceptibility to neurotoxic effects of amphetamine and to assess the potential role of superoxide radicals in amphetamine-induced dopaminergic damage, the drug was injected to mice with different levels of copper/zinc superoxide dismutase (Cu/Zn SOD) enzyme. Administration of amphetamine (10 mg/kg, i.p., given every 2 h, a total of four times) to wild-type CD-1 and C57BL/6J mice caused significant decreases in dopamine and 3,4-dihydroxyphenylacetic acid levels, in [125I]RTI-121-labeled dopamine transporters as well as a significant depletion in the concentration of dopamine transporter and vesicular monoamine transporter 2 proteins. The amphetamine-induced toxic effects were less prominent in CD-1 mice, which have much higher levels of Cu/Zn SOD activity (0.69 units/mg of protein) in their striata than C57BL/6J animals (0.007 units/mg of protein). Transgenic mice on CD-1 and C57BL/6J background, which had striatal levels of Cu/Zn SOD 2.57 and 1.67 units/mg of protein, respectively, showed significant protection against all the toxic effects of amphetamine. The attenuation of toxicity observed in transgenic mice was not caused by differences in amphetamine accumulation in wild-type and mutant animals. However, CD-1-SOD transgenic mice showed marked hypothermia to amphetamine whereas C57-SOD transgenic mice did not show a consistent thermic response to the drug. The data obtained demonstrate distinctions in the neurotoxic profile of amphetamine in CD-1 and C57BL/6J mice, which show some differences in Cu/Zn SOD activity and in their thermic responses to amphetamine administration. Thus, these observations provide evidence for possible complex interactions between thermoregulation and free radical load in the long-term neurotoxic effects of this illicit drug of abuse.

Original languageEnglish (US)
Pages (from-to)265-274
Number of pages10
JournalNeuroscience
Volume107
Issue number2
DOIs
StatePublished - Nov 16 2001

Fingerprint

Amphetamine
Inbred C57BL Mouse
Dopamine
Oxygen
Temperature
Transgenic Mice
Vesicular Monoamine Transport Proteins
Dopamine Plasma Membrane Transport Proteins
Poisons
Street Drugs
Hot Temperature
Corpus Striatum
3,4-Dihydroxyphenylacetic Acid
Dopamine Agents
Proteins
Wild Animals
Body Temperature Regulation
Hypothermia
Superoxides
Free Radicals

Keywords

  • Amphetamine
  • Antioxidant enzymes
  • Caudate-putamen
  • Dopamine
  • Superoxide radicals

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Amphetamine-induced toxicity in dopamine terminals in CD-1 and C57BL/6J mice : Complex roles for oxygen-based species and temperature regulation. / Krasnova, I. N.; Ladenheim, B.; Jayanthi, S.; Oyler, J.; Moran, Timothy H; Huestis, M. A.; Cadet, J. L.

In: Neuroscience, Vol. 107, No. 2, 16.11.2001, p. 265-274.

Research output: Contribution to journalArticle

Krasnova, I. N. ; Ladenheim, B. ; Jayanthi, S. ; Oyler, J. ; Moran, Timothy H ; Huestis, M. A. ; Cadet, J. L. / Amphetamine-induced toxicity in dopamine terminals in CD-1 and C57BL/6J mice : Complex roles for oxygen-based species and temperature regulation. In: Neuroscience. 2001 ; Vol. 107, No. 2. pp. 265-274.
@article{f2812fdca63a4b4ba4e721fee4542c7d,
title = "Amphetamine-induced toxicity in dopamine terminals in CD-1 and C57BL/6J mice: Complex roles for oxygen-based species and temperature regulation",
abstract = "In order to examine differential strain susceptibility to neurotoxic effects of amphetamine and to assess the potential role of superoxide radicals in amphetamine-induced dopaminergic damage, the drug was injected to mice with different levels of copper/zinc superoxide dismutase (Cu/Zn SOD) enzyme. Administration of amphetamine (10 mg/kg, i.p., given every 2 h, a total of four times) to wild-type CD-1 and C57BL/6J mice caused significant decreases in dopamine and 3,4-dihydroxyphenylacetic acid levels, in [125I]RTI-121-labeled dopamine transporters as well as a significant depletion in the concentration of dopamine transporter and vesicular monoamine transporter 2 proteins. The amphetamine-induced toxic effects were less prominent in CD-1 mice, which have much higher levels of Cu/Zn SOD activity (0.69 units/mg of protein) in their striata than C57BL/6J animals (0.007 units/mg of protein). Transgenic mice on CD-1 and C57BL/6J background, which had striatal levels of Cu/Zn SOD 2.57 and 1.67 units/mg of protein, respectively, showed significant protection against all the toxic effects of amphetamine. The attenuation of toxicity observed in transgenic mice was not caused by differences in amphetamine accumulation in wild-type and mutant animals. However, CD-1-SOD transgenic mice showed marked hypothermia to amphetamine whereas C57-SOD transgenic mice did not show a consistent thermic response to the drug. The data obtained demonstrate distinctions in the neurotoxic profile of amphetamine in CD-1 and C57BL/6J mice, which show some differences in Cu/Zn SOD activity and in their thermic responses to amphetamine administration. Thus, these observations provide evidence for possible complex interactions between thermoregulation and free radical load in the long-term neurotoxic effects of this illicit drug of abuse.",
keywords = "Amphetamine, Antioxidant enzymes, Caudate-putamen, Dopamine, Superoxide radicals",
author = "Krasnova, {I. N.} and B. Ladenheim and S. Jayanthi and J. Oyler and Moran, {Timothy H} and Huestis, {M. A.} and Cadet, {J. L.}",
year = "2001",
month = "11",
day = "16",
doi = "10.1016/S0306-4522(01)00351-7",
language = "English (US)",
volume = "107",
pages = "265--274",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Amphetamine-induced toxicity in dopamine terminals in CD-1 and C57BL/6J mice

T2 - Complex roles for oxygen-based species and temperature regulation

AU - Krasnova, I. N.

AU - Ladenheim, B.

AU - Jayanthi, S.

AU - Oyler, J.

AU - Moran, Timothy H

AU - Huestis, M. A.

AU - Cadet, J. L.

PY - 2001/11/16

Y1 - 2001/11/16

N2 - In order to examine differential strain susceptibility to neurotoxic effects of amphetamine and to assess the potential role of superoxide radicals in amphetamine-induced dopaminergic damage, the drug was injected to mice with different levels of copper/zinc superoxide dismutase (Cu/Zn SOD) enzyme. Administration of amphetamine (10 mg/kg, i.p., given every 2 h, a total of four times) to wild-type CD-1 and C57BL/6J mice caused significant decreases in dopamine and 3,4-dihydroxyphenylacetic acid levels, in [125I]RTI-121-labeled dopamine transporters as well as a significant depletion in the concentration of dopamine transporter and vesicular monoamine transporter 2 proteins. The amphetamine-induced toxic effects were less prominent in CD-1 mice, which have much higher levels of Cu/Zn SOD activity (0.69 units/mg of protein) in their striata than C57BL/6J animals (0.007 units/mg of protein). Transgenic mice on CD-1 and C57BL/6J background, which had striatal levels of Cu/Zn SOD 2.57 and 1.67 units/mg of protein, respectively, showed significant protection against all the toxic effects of amphetamine. The attenuation of toxicity observed in transgenic mice was not caused by differences in amphetamine accumulation in wild-type and mutant animals. However, CD-1-SOD transgenic mice showed marked hypothermia to amphetamine whereas C57-SOD transgenic mice did not show a consistent thermic response to the drug. The data obtained demonstrate distinctions in the neurotoxic profile of amphetamine in CD-1 and C57BL/6J mice, which show some differences in Cu/Zn SOD activity and in their thermic responses to amphetamine administration. Thus, these observations provide evidence for possible complex interactions between thermoregulation and free radical load in the long-term neurotoxic effects of this illicit drug of abuse.

AB - In order to examine differential strain susceptibility to neurotoxic effects of amphetamine and to assess the potential role of superoxide radicals in amphetamine-induced dopaminergic damage, the drug was injected to mice with different levels of copper/zinc superoxide dismutase (Cu/Zn SOD) enzyme. Administration of amphetamine (10 mg/kg, i.p., given every 2 h, a total of four times) to wild-type CD-1 and C57BL/6J mice caused significant decreases in dopamine and 3,4-dihydroxyphenylacetic acid levels, in [125I]RTI-121-labeled dopamine transporters as well as a significant depletion in the concentration of dopamine transporter and vesicular monoamine transporter 2 proteins. The amphetamine-induced toxic effects were less prominent in CD-1 mice, which have much higher levels of Cu/Zn SOD activity (0.69 units/mg of protein) in their striata than C57BL/6J animals (0.007 units/mg of protein). Transgenic mice on CD-1 and C57BL/6J background, which had striatal levels of Cu/Zn SOD 2.57 and 1.67 units/mg of protein, respectively, showed significant protection against all the toxic effects of amphetamine. The attenuation of toxicity observed in transgenic mice was not caused by differences in amphetamine accumulation in wild-type and mutant animals. However, CD-1-SOD transgenic mice showed marked hypothermia to amphetamine whereas C57-SOD transgenic mice did not show a consistent thermic response to the drug. The data obtained demonstrate distinctions in the neurotoxic profile of amphetamine in CD-1 and C57BL/6J mice, which show some differences in Cu/Zn SOD activity and in their thermic responses to amphetamine administration. Thus, these observations provide evidence for possible complex interactions between thermoregulation and free radical load in the long-term neurotoxic effects of this illicit drug of abuse.

KW - Amphetamine

KW - Antioxidant enzymes

KW - Caudate-putamen

KW - Dopamine

KW - Superoxide radicals

UR - http://www.scopus.com/inward/record.url?scp=0035900604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035900604&partnerID=8YFLogxK

U2 - 10.1016/S0306-4522(01)00351-7

DO - 10.1016/S0306-4522(01)00351-7

M3 - Article

C2 - 11731100

AN - SCOPUS:0035900604

VL - 107

SP - 265

EP - 274

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 2

ER -